Digi International Trims Stake — Is IoT Growth Real?
A Digi International VP sold a stake amid a fast-changing IoT landscape. This article breaks down what such insider m...
Verify budget accuracy with practical checks that align your projected spending to actuals. This quick intro helps you spot misalignments and tighten your budget.
11,585 articlesA Digi International VP sold a stake amid a fast-changing IoT landscape. This article breaks down what such insider m...
Three AI powerhouses eye the public markets. This guide breaks down how to compare SpaceX, Anthropic, and OpenAI IPOs...
Decision making in investing isn’t just about numbers. It’s shaped by psychology, trends, and how we interpret data. ...
Rumors swirl about a $1B annual AI deal behind Siri’s next leap. This article breaks down who benefits, how it change...
A Dutch court halted a welfare-detection AI system over privacy and bias concerns, prompting watchdogs to weigh tight...
A former NASDAQ chief warns that SpaceX’s unprecedented lockup could unlock roughly $800 billion in stock by October,...
When choosing biotech ETFs, investors face a trade-off between concentration and breadth. This article compares FBT a...
Two popular EM ETFs face off: schwab emerging markets ishares and EEM. This guide breaks down costs, performance, and...
Get a clear, investor-friendly view of Perion's 2025 earnings outlook. This guide explains revenue drivers, margins, ...
Kalshi has closed two insider trading investigations tied to a former California gubernatorial candidate and a mrbeas...
This fresh analysis explores intuit (intu) 2026 earnings, highlighting key growth drivers, profitability advances, an...
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.